Overall, the results from genetic modifications of HAVCR2 show that impaired TIM-3 function leads to dysregulated immune activation and increased proinflammatory cytokines, which is also frequently observed in autoimmune diseases. This evidence concerns the gene HAVCR2 and autoimmune disease.